STOCK TITAN

Insider share sale plans at PTCT (NASDAQ: PTCT) and recent proceeds

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of the issuer filed a notice of proposed sale of 1,789 shares of common stock, to be sold through Fidelity Brokerage Services LLC on or about 01/06/2026, with the shares listed on NASDAQ. These shares were acquired on 01/05/2026 through restricted stock vesting from the issuer as compensation.

As context, the filing reports 80,288,305 common shares outstanding. Over the prior three months, Eric Pauwels reported selling common shares in three transactions totaling 40,290; 3,202; and 20,508 shares, for gross proceeds of $3,038,755.33, $240,354.49, and $1,584,387.54, respectively.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the PTCT Form 144 filing disclose?

The filing discloses that an insider intends to sell 1,789 shares of common stock through Fidelity Brokerage Services LLC on or about 01/06/2026 on NASDAQ.

How were the PTCT shares to be sold acquired?

The 1,789 common shares to be sold were acquired on 01/05/2026 via restricted stock vesting from the issuer as compensation.

How many PTCT shares are reported as outstanding in this filing?

The notice reports that there were 80,288,305 common shares outstanding for the issuer.

What prior PTCT share sales by the insider are listed in the last 3 months?

The filing lists three prior sales by Eric Pauwels of common stock: 40,290 shares on 12/17/2025, 3,202 shares on 12/18/2025, and 20,508 shares on 12/19/2025.

What gross proceeds are disclosed for the recent PTCT share sales?

The disclosed gross proceeds are $3,038,755.33 for 40,290 shares on 12/17/2025, $240,354.49 for 3,202 shares on 12/18/2025, and $1,584,387.54 for 20,508 shares on 12/19/2025.

What representation does the selling person make in the PTCT Form 144 notice?

By signing the notice, the selling person represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

6.07B
78.25M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN